Jennifer Badik
Pediatric Endocrinology · Greensboro, NCNPI 1659529808
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,162 and has fallen 83.8% since, to $189 in 2025.
Across 86 payments — averaging $25.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$404
- AbbVie$385
- Tolmar Pharmaceuticals, Inc.$196
- Insulet Corporation$162
- Tandem Diabetes Care, Inc.$138
- Lilly USA, LLC$127
- plus $793 from 18 others
What the payments were for
- Food & beverage$2,00691%
- Education$1999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $404 |
| AbbVie | 14 | $385 |
| Tolmar Pharmaceuticals, Inc. | 7 | $196 |
| Insulet Corporation | 4 | $162 |
| Tandem Diabetes Care, Inc. | 6 | $138 |
| Lilly USA, LLC | 3 | $127 |
| Arbor Pharmaceuticals, Inc. | 6 | $121 |
| Ascendis Pharma Endocrinology Inc | 4 | $73 |
| AstraZeneca | 4 | $73 |
| Medtronic | 4 | $66 |
| Pfizer | 3 | $53 |
| Rhythm Pharmaceuticals, Inc. | 2 | $52 |
| Companion Medical, Inc. | 2 | $47 |
| Tolmar, Inc. | 2 | $42 |
| Boston Scientific | 2 | $42 |
| Sanofi-aventis U.S. LLC | 1 | $38 |
| Abbott | 2 | $37 |
| IBSA Pharma Inc. | 2 | $31 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Roche Diabetes Care, Inc. | 1 | $19 |
| Soleno Therapeutics, Inc. | 1 | $16 |
| Senseonics, Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sogroya$125
- Omnipod$107
- t-slim insulin pump$105
- BAQSIMI$100
How this compares
$2,205 in reported general payments places this provider in the 65th percentile of 46 pediatric endocrinology providers in North Carolina.
See all pediatric endocrinology providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $9,683 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Greensboro
- Colette MeehanGreensboro$3K
- Michael BrennanGreensboro$3K
- Susan TuckerGreensboro$171
- Kristina TeutonicoGreensboro$110
- Mark VanderwelCharlotte$42K
- Jennifer LawChapel Hill$40K
- Jakub MieszczakCharlotte$34K
- Nina JainSanford$22K
- Olga GuptaDurham$22K
- Hillary LockemerRaleigh$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.